![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
SAPPHIRE-I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/r/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAĻVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Jordan J. Feld, Kris V. Kowdley, Eoin Coakley, Samuel Sigal, David Nelson, Darrell Crawford, Ola Weiland, Humberto Aguilar, Junyuan Julia Xiong, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki
![EASL1.gif](../images/041114/041114-5/EASL1.gif)
![EASL2.gif](../images/041114/041114-5/EASL2.gif)
![EASL4.gif](../images/041114/041114-5/EASL4.gif)
![EASL5.gif](../images/041114/041114-5/EASL5.gif)
![EASL6.gif](../images/041114/041114-5/EASL6.gif)
![EASL7.gif](../images/041114/041114-5/EASL7.gif)
![EASL8.gif](../images/041114/041114-5/EASL8.gif)
![EASL9.gif](../images/041114/041114-5/EASL9.gif)
![EASL10.gif](../images/041114/041114-5/EASL10.gif)
![EASL11.gif](../images/041114/041114-5/EASL11.gif)
![EASL12.gif](../images/041114/041114-5/EASL12.gif)
![EASL13.gif](../images/041114/041114-5/EASL13.gif)
![EASL14.gif](../images/041114/041114-5/EASL14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|